Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • CORRESPONDENCE

Account for sex in brain research for precision medicine

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 569, 40 (2019)

doi: https://doi.org/10.1038/d41586-019-01366-5

Competing Interests

A.S.-C. is an employee of Roche Diagnostics International, Rotkreuz, Switzerland.

H.H. serves as senior associate editor for the journal Alzheimer’s & Dementia; he received lecture fees from Biogen and Roche, research grants from Pfizer, Avid and MSD Avenir (paid to the institution), travel funding from Eisai, Functional Neuromodulation, Axovant, Eli Lilly and Company, Takeda and Zinfandel, GE-Healthcare and Oryzon Genomics, consultancy fees from Qynapse, Jung Diagnostics, Cytox, Axovant, Anavex, Takeda and Zinfandel, GE Healthcare, Oryzon Genomics, and Functional Neuromodulation, and participated in scientific advisory boards of Functional Neuromodulation, Axovant, Eisai, Eli Lilly and Company, Cytox, GE Healthcare, Takeda and Zinfandel, Oryzon Genomics and Roche Diagnostics.

H.H. is co-inventor in the following patents as a scientific expert and has received no royalties:

• In Vitro Multiparameter Determination Method for the Diagnosis and Early Diagnosis of Neurodegenerative Disorders, Patent Number: 8916388

• In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases, Patent Number: 8298784

• Neurodegenerative Markers for Psychiatric Conditions, Publication Number: 20120196300

• In Vitro Multiparameter Determination Method for the Diagnosis and Early Diagnosis of Neurodegenerative Disorders, Publication Number: 20100062463

• In Vitro Method for the Diagnosis and Early Diagnosis of Neurodegenerative Disorders, Publication Number: 20100035286

• In Vitro Procedure for Diagnosis and Early Diagnosis of Neurodegenerative Diseases, Publication Number: 20090263822

• In Vitro Method for the Diagnosis of Neurodegenerative Diseases, Patent Number: 7547553

• CSF Diagnostic in Vitro Method for Diagnosis of Dementias and Neuroinflammatory Diseases, Publication Number: 20080206797

• In Vitro Method for The Diagnosis of Neurodegenerative Diseases, Publication Number: 20080199966

• Neurodegenerative Markers for Psychiatric Conditions, Publication Number: 20080131921

M.T.F. acts as the unpaid chief scientific officer of the non-profit organization Woman’s Brain Project.

A.S.-C. acts as the unpaid chief executive of the non-profit organization Woman’s Brain Project.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links